Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02335021 · ClinicalTrials.gov registry record · NA

The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adults

A NA study of Insulin Resistance and Impairment of Oral Perception, sponsored by Yale University.

Completed
Registry status
NA
Development phase
97
Enrollment target
1
Study location

NCT02335021 is a NA study of Insulin Resistance and Impairment of Oral Perception that has completed, run by Yale University. The registered enrollment target is 97 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02335021, a NA study of Insulin Resistance and Impairment of Oral Perception, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
97 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the effects of dietary exposure to artificial sweeteners on taste sensitivity, preference and brain response in adults. The investigators hypothesize that dietary exposure to artificial sweeteners (sucralose) will decrease sensitivity to taste, shift preference of sweet and savory taste to a higher dose, and reduce brain response in amygdala to sweet taste compared to sucrose.

Interventions

  • DIETARY_SUPPLEMENT Sucrose
  • DIETARY_SUPPLEMENT Sucralose
  • DIETARY_SUPPLEMENT Sucralose + maltodextrin
  • DIETARY_SUPPLEMENT Sucralose + Sucrose

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2015-01-01
Est. Completion 2019-04-24
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT02335021

The ClinicalTrials.gov registry entry for NCT02335021 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (60% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 4 interventions - of which Sucrose is the first listed.

NCT02335021 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02335021 about?

NCT02335021 is a clinical study titled "The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adults". The purpose of this study is to investigate the effects of dietary exposure to artificial sweeteners on taste sensitivity, preference and brain response in adults. The investigators hypothesize that dietary exposure to artificial sweeteners (sucralose) will decrease sensitivity to taste, shift prefe...

What is the current status of trial NCT02335021?

This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2015-01-01. Estimated completion is 2019-04-24.

What conditions does trial NCT02335021 study?

This clinical trial studies the following conditions: Insulin Resistance, Impairment of Oral Perception.

What interventions are being tested in trial NCT02335021?

The interventions under investigation include: Sucrose (DIETARY_SUPPLEMENT), Sucralose (DIETARY_SUPPLEMENT), Sucralose + maltodextrin (DIETARY_SUPPLEMENT), Sucralose + Sucrose (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02335021?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02335021 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.